Medartis Holding AG Logo

Medartis Holding AG

Global provider of high-precision implants & instruments for surgical fracture fixation.

MED | SW

Overview

Corporate Details

ISIN(s):
CH0386200239
LEI:
506700VUSP6HG3F28846
Country:
Switzerland
Address:
Hochbergerstr. 60E, 4057 Basel
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Medartis Holding AG is a global medical device company that develops, manufactures, and distributes high-precision implants and instruments for surgical fracture fixation. The company specializes in osteosynthesis solutions for the upper and lower extremities, as well as the craniomaxillofacial skeleton. Its product portfolio includes titanium screws, plates, and system solutions, marketed under brands like APTUS, MODUS, and StealthFix. Medartis serves surgeons, hospitals, and medical centers worldwide, emphasizing its Swiss engineering and manufacturing standards to provide advanced, best-in-class technology. In 2023, the company expanded its lower extremities portfolio through the acquisition of U.S.-based Nextremity Solutions Inc.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 06:59
Board/Management Information
Medartis appoints Peter Hackel as new Chief Financial Officer
English 6.0 KB
2025-11-24 01:00
Board/Management Information
Medartis appoints Peter Hackel as new Chief Financial Officer
English 9.3 KB
2025-11-24 01:00
Board/Management Information
Medartis ernennt Peter Hackel zum neuen Finanzchef
German 10.2 KB
2025-08-19 06:58
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 58.8 KB
2025-08-19 02:00
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 65.2 KB
2025-08-19 02:00
Earnings Release
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % u…
German 67.9 KB
2025-07-30 09:59
Regulatory News Service
Medartis 2025 half-year results webcast
English 11.1 KB
2025-07-17 06:59
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 11.8 KB
2025-07-17 02:00
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 15.5 KB
2025-07-17 02:00
M&A Activity
Medartis erwirbt restliche 53 % der Anteile an KeriMedical
German 16.3 KB
2025-03-19 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 01:00
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 61.8 KB
2025-03-18 01:00
Earnings Release
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-…
German 63.2 KB
2024-08-20 07:05
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 51.0 KB

Automate Your Workflow. Get a real-time feed of all Medartis Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medartis Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medartis Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-25 N/A Non-Executive member Buy None 176,411.02 CHF
2025-04-10 N/A Non-Executive member Buy None 37,500.00 CHF
2025-04-08 N/A Non-Executive member Buy None 375,000.00 CHF
2024-12-30 N/A Non-Executive member Buy None 4,999,956.00 CHF
2024-12-20 N/A Executive member Buy None 5,120.00 CHF
2024-12-19 N/A Executive member Buy None 5,300.00 CHF
2024-12-17 N/A Executive member Buy None 16,200.00 CHF
2024-12-16 N/A Executive member Buy None 2,214.00 CHF
2024-12-12 N/A Executive member Buy None 1,188.00 CHF
2024-12-11 N/A Executive member Buy None 72,795.60 CHF

Peer Companies

TRINITY BIOTECH PLC Logo
Develops and markets clinical diagnostic test kits and biosensors for labs and point-of-care.
United States of America
TRIB
TriSalus Life Sciences, Inc. Logo
Oncology tech firm enhancing drug delivery and immunotherapy for solid liver & pancreas tumors.
United States of America
TLSI
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom
TSP
Twist Bioscience Corp Logo
Offers scalable DNA synthesis on silicon for research, drug discovery, and diagnostics.
United States of America
TWST
UFP TECHNOLOGIES INC Logo
Designs & manufactures custom products from advanced materials for MedTech, aerospace & auto markets.
United States of America
UFPT
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy
UBM
UTAH MEDICAL PRODUCTS INC Logo
Develops specialty medical devices to improve healthcare outcomes for women and their babies.
United States of America
UTMD
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea
337840
Venus Concept Inc. Logo
Develops aesthetic & hair restoration systems for professionals on a subscription model.
United States of America
VERO
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany
VMED

Talk to a Data Expert

Have a question? We'll get back to you promptly.